|
Volumn 3, Issue 3 Supplement, 1993, Pages 21-27
|
Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin
a b c d e e d f g h f e e f f
d
MSD Italia
(Italy)
|
Author keywords
Alendronate; Bisphosphonates; Calcitonin; Osteoporosis; Postmeno pausal
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM GLUBIONATE;
HORMONE;
SALCATONIN;
ADULT;
AGED;
BONE ATROPHY;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BONE TURNOVER;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FEMALE;
FEMUR;
FEMUR NECK;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
ITALY;
LUMBAR SPINE;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
OSTEOLYSIS;
POSTMENOPAUSE OSTEOPOROSIS;
VERTEBRA FRACTURE;
ADMINISTRATION, INTRANASAL;
ADMINISTRATION, ORAL;
AGED;
ALENDRONATE;
ALKALINE PHOSPHATASE;
BONE DENSITY;
CALCITONIN;
COMPARATIVE STUDY;
DIPHOSPHONATES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMAN;
MIDDLE AGE;
OSTEOPOROSIS, POSTMENOPAUSAL;
|
EID: 0027453805
PISSN: 0937941X
EISSN: 14332965
Source Type: Journal
DOI: 10.1007/BF01623004 Document Type: Article |
Times cited : (73)
|
References (33)
|